The New York Times profiles Eric Schadt, the chief scientific officer of Pacific Biosciences, from his days in the Air Force to working with his new nonprofit, Sage Bionetworks. In the article Schadt is heralded for his unconventional approach — both to his research and attire. The new venture, Sage, has received data and hardware from Merck's Rosetta subsidiary, where Schadt worked until recently.